Page last updated: 2024-08-23

daurisoline and Liver Neoplasms

daurisoline has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Li, Q; Liu, GL; Mu, W; Zhang, JG; Zhang, X; Zhou, HM1
Liu, P; Xue, L1

Other Studies

2 other study(ies) available for daurisoline and Liver Neoplasms

ArticleYear
The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 92

    Topics: Animals; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Mice; Neovascularization, Pathologic; Sorafenib

2021
Daurisoline inhibits hepatocellular carcinoma progression by restraining autophagy and promoting cispaltin-induced cell death.
    Biochemical and biophysical research communications, 2021, 01-01, Volume: 534

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Disease Progression; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Nude

2021
chemdatabank.com